BioSpace News Archive

This week, the first patients are enrolling in two phase 2 clinical trials for COVID-19 using Pulmotect’s PUL-042, an inhaled immunomodulatory agent to prevent and treat coronavirus infections, delivered by PARI’s LC Sprint Reusable Nebulizer.

Enhanced Design Offers Improved Ergonomics and Procedural Efficiency for the Only Device that Targets the Three Points of Resistance in the Conventional Outflow Pathway

Event featuring renowned myelofibrosis expert Dr. Ruben Mesa scheduled for 10:00 am ET on Wednesday, May 13th

Halozyme Therapeutics, Inc., will participate in the Bank of America Securities 2020 Healthcare Conference.

Genelux Corporation, a privately-held, clinical-stage immunotherapy company, today announced the outcome of a Type C meeting with the U.S. Food and Drug Administration (FDA) held on M

This DOD-funded initiative will assess the role of home-based continuous biosensor data and AI analytics in addressing the global COVID-19 crisis.

UroGen Pharma Ltd. (Nasdaq: URGN), a biopharmaceutical company dedicated to building and commercializing novel solutions that treat specialty cancers and urologic diseases, today announced financial results for the first quarter ended March 31, 2020 and provided an overview of the Company’s recent developments.

WebMD Health Services has integrated a weekly podcast on mental health issues – including those emerging during the COVID-19 pandemic – to provide employers with timely, evidence-based insights to support their employees’ mental and emotional well-being.

The National University Cancer Institute, Singapore, partners with Varian to extend advanced oncology solutions to cancer patients

CANbridge Pharmaceuticals Inc., a biopharmaceutical company developing innovative drug candidates to treat underserved medical conditions in China and other markets, announced that it has received marketing approval from China’s National Medical Products Administration (NMPA) for NERLYNX ® (neratinib) for the extended adjuvant